Posts tagged: Catalent
Monday, 5 February 2024, 11:24 am
It would appear pharmaceuticals and biotechnology is still a fertile industry for dealmaking.
Novo Holdings, the largest shareholder in Danish drugs giant Novo Nordisk, just announced the $16.5 billion takeover of US-listed Catalent, provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products...
Read more...
Sunday, 5 February 2023, 6:17 am
Bloomberg dug out the biggest takeover scoop of the weekend.
The financial media giant revealed that Danaher Corporation, the US-listed life sciences giant, has recently expressed an interest in buying Catalent, a healthcare contract manufacturer.
Bloomberg suggests Danaher indicated it could be willing to pay a significant premium for Catalent, so the latter's shares may be sharply up on Monday...
Read more...
Thursday, 11 August 2022, 9:17 pm
Betaville notes rivals at StreetInsider have picked up on the Repligen Corporation takeover rumour that has been doing the rounds in the last few days.
According to StreetInsider, Catalent - a US-listed biopharmaceutical company - has been circling Repligen, which makes materials used in the manufacture of biological drugs...
Read more...